US Bancorp’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

US Bancorp’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12	Closed	–	–	3790
2018 Q3	$0	Hold	12	–	–	﹤0.01%	3759
2018 Q2	$4K	Hold	12	–	–	﹤0.01%	3404
2018 Q1	$36K	Hold	12	–	–	﹤0.01%	2759
2017 Q4	$37K	Buy	+12	New	+$39.7K	﹤0.01%	2732

Other funds holding RSLS

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

US Bancorp's RSLS Position: Q4 2018 in Review

US Bancorp sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 12 shares.

US Bancorp first reported a position in RSLS in Q4 2017 and held it in 4 quarters. The position peaked at $37K in Q4 2017. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

US Bancorp reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
US Bancorp sold 12 ReShape Lifesciences Inc. Common Stock shares in Q4 2018.
US Bancorp first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2017 and held it in 4 quarters.
US Bancorp's ReShape Lifesciences Inc. Common Stock position peaked at $37K in Q4 2017.
2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on US Bancorp's 13F filing for Q4 2018, filed 13 Feb 2019.